République tchèque - tchèque - Adama

adama - emulgovatelný koncentrát - fluroxypyr - herbicidy

République tchèque - tchèque - Adama

adama - suspenzní koncentrát - chlorotoluron + diflufenican + pendimethalin - herbicidy

Union européenne - tchèque - EMA (European Medicines Agency)

kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - lymfom, mantle-cell - antineoplastická činidla - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).

République tchèque - tchèque - Adama

adama - suspenzní emulze - ethofumesate + metamitron - herbicidy

République tchèque - tchèque - Adama

adama - suspenzní koncentrát - metamitron + quinmerac - herbicidy

Union européenne - tchèque - EMA (European Medicines Agency)

novartis europharm limited - tisagenlecleucel - precursor b-cell lymphoblastic leukemia-lymphoma; lymphoma, large b-cell, diffuse - další antineoplastické látky - kymriah is indicated for the treatment of:• paediatric and young adult patients up to and including 25 years of age with b cell acute lymphoblastic leukaemia (all) that is refractory, in relapse post transplant or in second or later relapse. • adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl) after two or more lines of systemic therapy. • adult patients with relapsed or refractory follicular lymphoma (fl) after two or more lines of systemic therapy.

République tchèque - tchèque - Adama

adama - suspenzní emulze - florasulam + fluroxypyr - herbicidy